Related references
Note: Only part of the references are listed.Branched oligomerization of cell-permeable peptides markedly enhances the transduction efficiency of adenovirus into mesenchymal stem cells
S-H Park et al.
GENE THERAPY (2010)
Chemotherapy-Associated Hepatotoxicity: Do We Need to Be Concerned?
Michael A. Choti
ANNALS OF SURGICAL ONCOLOGY (2009)
Mesenchymal Stem Cell Delivery of TRAIL Can Eliminate Metastatic Cancer
Michael R. Loebinger et al.
CANCER RESEARCH (2009)
Mesenchymal Stem Cells: Flip Side of the Coin
Pravin J. Mishra et al.
CANCER RESEARCH (2009)
Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation
Sang Hwan Seo et al.
VACCINE (2009)
Antitumor mechanism of intratumoral injection with IL-12-expressing adenoviral vector against IL-12-unresponsive tumor
Naoko Kanagawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Enhanced delivery efficiency of recombinant adenovirus into tumor and mesenchymal stem cells by a novel PTD
J-I Youn et al.
CANCER GENE THERAPY (2008)
Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling
Ling Qiao et al.
CANCER LETTERS (2008)
Neo-organoid of marrow mesenchymal stromal cells secreting interleukin-12 for breast cancer therapy
Nicoletta Eliopoulos et al.
CANCER RESEARCH (2008)
Cancer gene therapy using mesenchymal stem cells expressing interferon-β in a mouse prostate cancer lung metastasis model
C. Ren et al.
GENE THERAPY (2008)
Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells
Ilaria Marigo et al.
IMMUNOLOGICAL REVIEWS (2008)
A tumor-selective biotherapy with prolonged impact on established metastases based on cytokine gene-engineered MSCs
Xiancheng Chen et al.
MOLECULAR THERAPY (2008)
Therapeutic potential of mesenchymal stem cells producing interferon-α in a mouse melanoma lung metastasis model
Changchun Ren et al.
STEM CELLS (2008)
Spontaneous expression of embryonic factors and p53 point mutations in aged mesenchymal stem cells: A model of age-related tumorigenesis in mice
Hanchen Li et al.
CANCER RESEARCH (2007)
Spontaneous transformation of cultured mouse bone marrow-derived stromal cells
Yi Fu Zhou et al.
CANCER RESEARCH (2006)
Anti-tumor activity of mesenchymal stem cells producing IL-12 in a mouse melanoma model
Lina Elzaouk et al.
EXPERIMENTAL DERMATOLOGY (2006)
Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model
Young-Sook Lee et al.
CLINICAL CANCER RESEARCH (2006)
Administration route- and immune cell activation-dependent tumor eradication by IL12 electrotransfer
SL Li et al.
MOLECULAR THERAPY (2005)
Bone marrow mesenchymal stem cefls induce division arrest anergy of activated T cells
S Glennie et al.
BLOOD (2005)
Enhancement of interleukin-12 gene-based tumor immunotherapy by the reduced secretion of p40 subunit and the combination with farnesyltransferase inhibitor
HT Jin et al.
HUMAN GENE THERAPY (2005)
Mesenchymal stem cells: clinical applications and biological characterization
FP Barry et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
Antitumor effects of vaccine consisting of dendritic cells pulsed with tumor RNA from gastric cancer
Bing-Ya Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2004)
Cytokines in cancer pathogenesis and cancer therapy
G Dranoff
NATURE REVIEWS CANCER (2004)
Mesenchymal stem cells: Potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents
M Studeny et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors
JW Shiver et al.
ANNUAL REVIEW OF MEDICINE (2004)
A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice
N Eliopoulos et al.
GENE THERAPY (2003)
Prolonged IFN-γ-producing NKT response induced with α-galactosylceramide-loaded DCs
S Fujii et al.
NATURE IMMUNOLOGY (2002)
Engineering N-glycosylation mutations in IL-12 enhances sustained cytotoxic T lymphocyte responses for DNA immunization
SJ Ha et al.
NATURE BIOTECHNOLOGY (2002)
Interleukin-12 in anti-tumor immunity and immunotherapy
MP Colombo et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
Gene gun-mediated oral mucosal transfer of interleukin 12 cDNA coupled with an irradiated melanoma vaccine in a hamster model: Successful treatment of oral melanoma and distant skin lesion
J Wang et al.
CANCER GENE THERAPY (2001)
In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice
T Kishida et al.
GENE THERAPY (2001)
A fresh look at tumor immunosurveillance and immunotherapy
MJ Smyth et al.
NATURE IMMUNOLOGY (2001)
Share Paper
